Colleen LaBelle

1.4k total citations
21 papers, 941 citations indexed

About

Colleen LaBelle is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Clinical Psychology. According to data from OpenAlex, Colleen LaBelle has authored 21 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Public Health, Environmental and Occupational Health and 4 papers in Clinical Psychology. Recurrent topics in Colleen LaBelle's work include Opioid Use Disorder Treatment (14 papers), Substance Abuse Treatment and Outcomes (13 papers) and HIV, Drug Use, Sexual Risk (4 papers). Colleen LaBelle is often cited by papers focused on Opioid Use Disorder Treatment (14 papers), Substance Abuse Treatment and Outcomes (13 papers) and HIV, Drug Use, Sexual Risk (4 papers). Colleen LaBelle collaborates with scholars based in United States and South Sudan. Colleen LaBelle's co-authors include Jeffrey H. Samet, Daniel P. Alford, Steve C. Han, Debbie M. Cheng, Jessica Richardson, Michael Winter, Michael Botticelli, Natalie Kretsch, Zoe Weinstein and Emily Quinn and has published in prestigious journals such as Clinical Infectious Diseases, Journal of General Internal Medicine and Drug and Alcohol Dependence.

In The Last Decade

Colleen LaBelle

18 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colleen LaBelle United States 13 666 655 211 180 97 21 941
Petra Jacobs United States 16 666 1.0× 877 1.3× 127 0.6× 325 1.8× 148 1.5× 40 1.3k
Darius A. Rastegar United States 18 348 0.5× 365 0.6× 99 0.5× 100 0.6× 188 1.9× 47 851
Alexander R. Bazazi United States 17 611 0.9× 396 0.6× 138 0.7× 125 0.7× 300 3.1× 37 867
Andrew Ivsins Canada 23 845 1.3× 639 1.0× 345 1.6× 114 0.6× 69 0.7× 52 1.2k
Dominick DePhilippis United States 15 664 1.0× 360 0.5× 271 1.3× 114 0.6× 275 2.8× 28 1.1k
Mary A. Hatch‐Maillette United States 16 527 0.8× 362 0.6× 325 1.5× 157 0.9× 212 2.2× 39 962
Lynn M. Madden United States 20 741 1.1× 569 0.9× 317 1.5× 101 0.6× 335 3.5× 95 1.2k
Michael Botsko United States 18 721 1.1× 440 0.7× 296 1.4× 141 0.8× 612 6.3× 24 1.3k
Alex Harocopos United States 13 565 0.8× 604 0.9× 84 0.4× 163 0.9× 99 1.0× 32 820
Sabina Dobrer Canada 20 714 1.1× 342 0.5× 131 0.6× 83 0.5× 297 3.1× 42 926

Countries citing papers authored by Colleen LaBelle

Since Specialization
Citations

This map shows the geographic impact of Colleen LaBelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen LaBelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen LaBelle more than expected).

Fields of papers citing papers by Colleen LaBelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen LaBelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen LaBelle. The network helps show where Colleen LaBelle may publish in the future.

Co-authorship network of co-authors of Colleen LaBelle

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen LaBelle. A scholar is included among the top collaborators of Colleen LaBelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen LaBelle. Colleen LaBelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matson, Theresa E., Amy K. Lee, Edward J. Miech, et al.. (2025). The difference-making role of staff support in implementing nurse care management for opioid use disorder treatment: A configurational analysis. Journal of Substance Use and Addiction Treatment. 172. 209642–209642.
2.
LaBelle, Colleen, et al.. (2025). Harm Reduction Is Nursing Practice. AJN American Journal of Nursing. 125(2). 8–8.
3.
Ventura, Alicia S., et al.. (2024). Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine. Journal of Addiction Medicine. 18(6). 723–726. 2 indexed citations
4.
Ventura, Alicia S., et al.. (2024). Xylazine and Adulterants in the Evolving Drug Supply: Urgent Call for Responsive Education Models. PubMed. 45(2). 168–175. 6 indexed citations
5.
Brett, Meghan, et al.. (2023). Starting the Discussion: A Call to Enhance Care for People With Stimulant Use Disorder. Substance Abuse. 44(3). 115–120. 1 indexed citations
6.
7.
Caputo, Andrea, et al.. (2021). Addiction Nursing Competencies. JONA The Journal of Nursing Administration. 51(9). 424–429. 8 indexed citations
8.
Tsui, Judith I., Brian G. Leroux, Kendra L. Blalock, et al.. (2021). Video directly observed therapy for patients receiving office-based buprenorphine – A pilot randomized controlled trial. Drug and Alcohol Dependence. 227. 108917–108917. 13 indexed citations
9.
Komaromy, Miriam, Jessica L. Taylor, Simeon D. Kimmel, et al.. (2020). Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. Journal of Addiction Medicine. 15(6). 448–451. 19 indexed citations
10.
Weinstein, Zoe, Debbie M. Cheng, Emily Quinn, et al.. (2018). Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug and Alcohol Dependence. 189. 166–171. 16 indexed citations
11.
Bagley, Sarah M., Debbie M. Cheng, Michael Winter, et al.. (2018). Opioid and cocaine use among primary care patients on buprenorphine—Self-report and urine drug tests. Drug and Alcohol Dependence. 192. 245–249. 13 indexed citations
12.
Hui, David S.C., Zoe Weinstein, Debbie M. Cheng, et al.. (2017). Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. Journal of Substance Abuse Treatment. 79. 12–19. 22 indexed citations
13.
Weinstein, Zoe, Hyun-Joong Kim, Debbie M. Cheng, et al.. (2016). Long-term retention in Office Based Opioid Treatment with buprenorphine. Journal of Substance Abuse Treatment. 74. 65–70. 167 indexed citations
14.
LaBelle, Colleen, et al.. (2015). Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers. Journal of Substance Abuse Treatment. 60. 6–13. 168 indexed citations
15.
Alford, Daniel P., Colleen LaBelle, Natalie Kretsch, et al.. (2011). Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine. Archives of Internal Medicine. 171(5). 425–31. 215 indexed citations
16.
Saitz, Richard, Mary Jo Larson, Colleen LaBelle, Jessica Richardson, & Jeffrey H. Samet. (2008). The Case for Chronic Disease Management for Addiction. Journal of Addiction Medicine. 2(2). 55–65. 113 indexed citations
17.
Alford, Daniel P., Colleen LaBelle, Jessica Richardson, et al.. (2007). Treating Homeless Opioid Dependent Patients with Buprenorphine in an Office-Based Setting. Journal of General Internal Medicine. 22(2). 171–176. 91 indexed citations
18.
Linden, Judith A., et al.. (2005). HIV Postexposure Prophylaxis in Sexual Assault: Current Practice and Patient Adherence to Treatment Recommendations in a Large Urban Teaching Hospital. Academic Emergency Medicine. 12(7). 640–646. 15 indexed citations
19.
Crosby, Sondra S., et al.. (2003). Acute Human Immunodeficiency Virus Infection in Patients Presenting to an Urban Urgent Care Center. Clinical Infectious Diseases. 37(12). 1699–1704. 53 indexed citations
20.
Moreno, Alejandro, Colleen LaBelle, & Jeffrey H. Samet. (2003). Recurrence of post‐traumatic stress disorder symptoms after initiation of antiretrovirals including efavirenz: a report of two cases. HIV Medicine. 4(3). 302–304. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Jacobs Breakdown of academic impact, for papers by Darius A. Rastegar Breakdown of academic impact, for papers by Alexander R. Bazazi Breakdown of academic impact, for papers by Andrew Ivsins Breakdown of academic impact, for papers by Dominick DePhilippis Breakdown of academic impact, for papers by Mary A. Hatch‐Maillette Breakdown of academic impact, for papers by Lynn M. Madden Breakdown of academic impact, for papers by Michael Botsko Breakdown of academic impact, for papers by Alex Harocopos Breakdown of academic impact, for papers by Sabina Dobrer
Rankless by CCL
2026